GSK demerger carries risks as it pegs future to R&D progress

Wednesday 5th February 2020 18:00 GMT


It had been signalled just over a year ago but, on Wednesday, the healthcare giant GlaxoSmithKline (GSK) confirmed it was to break itself up.

The full article is no longer available.